Therapeutic Antibodies – Major Driver for Chromatography Resins Market in Drug Discovery

The global chromatography resins market in drug discovery is driven by the increased demand for therapeutic monoclonal antibodies. The increasing prevalence of critical diseases such as cancer and Alzheimer’s has spurred the demand for therapeutic antibodies. The biopharmaceutical companies have increased their research pipeline of these monoclonal antibody drugs. Chromatography is an essential step during purification of protein and other biomolecules. Hence, the demand for chromatography resins for drug discovery will be high in the coming years.

The chromatography resins market in drug discovery is expected to grow at a high rate of 7.0% between 2015 and 2020, in terms of value. The market is projected to reach $359.88 Million by 2020. North America is the largest consumer of chromatography resins for drug discovery and accounts for around 50.0% of the market in terms of value. The growth in this region is mainly driven by demand from the U.S. The country is one of the leading bio-pharmaceutical research destinations. Also, research centers of some of the key bio-pharmaceutical companies of the world are located in the region.

Asia-Pacific is the fastest growing market for chromatography resins in drug discovery application. The demand in Asia-Pacific is driven by the increased research and development in the region. Asia-Pacific is rapidly progressing in the field of drug discovery research. The key bio-pharmaceutical companies have been establishing their R&D center in the region due to the availability of skilled professionals and cheap raw materials. The growing number of Contract Research Organizations (CROs) in the bio-pharmaceutical research field is expected to drive the demand for chromatography resins in the region.

Download Free Sample Pages:
http://www.marketsandmarkets.com/requestsample.asp?id=29294329